| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9988796 | Clinical Neurophysiology | 2018 | 8 Pages |
Abstract
Extreme delta may be a surrogate marker of disease activity in NMDARE refractory to first line immunotherapy.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Claude Steriade, Stephen Hantus, Ahsan N.V. Moosa, Alexander D. Rae-Grant,